Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

Clinical trial NCT06899464 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06899464
Sponsor: Cardinal Stefan Wyszynski University
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Intracerebral Hemorrhage Hemorrhagic Stroke, Intracerebral Hemorrhagic Stroke Stroke

Start date: 2025-10-01
Primary completion: 2027-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.